← Back to Search

Rise - Treatment Education for HIV/AIDS

N/A
Waitlist Available
Research Sponsored by RAND
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (pre-treatment) and post-treatment observations at 7 and 12 months post-baseline
Awards & highlights

Study Summary

This trial is testing a new education intervention for African Americans with HIV that focuses on cultural and social issues that contribute to health disparities.

Eligible Conditions
  • HIV/AIDS

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (pre-treatment) and post-treatment observations at 7, 8, 9, 10, 11, and 12 months post-baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (pre-treatment) and post-treatment observations at 7, 8, 9, 10, 11, and 12 months post-baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Continuous Adherence
Dichotomous Adherence
Viral Suppression
Secondary outcome measures
Internalized HIV Stigma
Medical Mistrust

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Rise - Treatment EducationExperimental Treatment1 Intervention
Rise consists of a one-month intensive intervention (with three core 60-minute counseling sessions at weeks 1, 2, and 4) followed by two booster sessions (at weeks 12 and 20). If participants show nonadherence during booster sessions, they are offered up to four additional booster sessions (i.e., extra booster sessions if <85% of prescribed doses were taken in the past month). Thus, participants receive three core sessions in the first month, followed by 2-6 booster sessions over the next four months.
Group II: Control - No Treatment EducationActive Control1 Intervention
The Usual Care control group will only receive standard of care through their HIV clinics.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Rise - Treatment Education
2018
N/A
~310

Find a Location

Who is running the clinical trial?

RANDLead Sponsor
137 Previous Clinical Trials
509,945 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
JAIDS Journal of Acquired Immune Deficiency SyndromesJournal
Efficacy of Antiretroviral Therapy Adherence Interventions
Rivet Amico, K., Jennifer J. Harman, and Blair T. Johnson. 2006. “Efficacy of Antiretroviral Therapy Adherence Interventions”. JAIDS Journal of Acquired Immune Deficiency Syndromes. Ovid Technologies (Wolters Kluwer Health). doi:10.1097/01.qai.0000197870.99196.ea.
Annual Review of Public HealthJournal
REVIEW OF COMMUNITY-BASED RESEARCH: Assessing Partnership Approaches to Improve Public Health
Israel, Barbara A., Amy J. Schulz, Edith A. Parker, and Adam B. Becker. 1998. “REVIEW OF COMMUNITY-BASED RESEARCH: Assessing Partnership Approaches to Improve Public Health”. Annual Review of Public Health. Annual Reviews. doi:10.1146/annurev.publhealth.19.1.173.
Journal of General Internal MedicineJournal
The PHQ-9
Kroenke, Kurt, Robert L. Spitzer, and Janet B. W. Williams. 2001. “The PHQ-9”. Journal of General Internal Medicine. Springer Science and Business Media LLC. doi:10.1046/j.1525-1497.2001.016009606.x.
AIDS CareJournal
HIV Multidisciplinary Teams Work: Support Services Improve Access to and Retention in HIV Primary Care
Sherer, R., K. Stieglitz, J. Narra, J. Jasek, L. Green, B. Moore, S. Shott, and M. Cohen. 2002. “HIV Multidisciplinary Teams Work: Support Services Improve Access to and Retention in HIV Primary Care”. AIDS Care. Informa UK Limited. doi:10.1080/09540120220149975.
~42 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top